>. Guillermo’s Story. ... Revenue. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Privacy Policy | No cost, no obligation to buy anything ever. So, the shares are expected to perform in line with the market in the near future. While Guardant Health has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Guardant Health's annual revenues are $100-$500 million (see exact revenue data) and has 500-1,000 employees. August 06, 2020. NASDAQ data is at least 15 minutes delayed. Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. the complete list of today's Zacks #1 Rank (Strong Buy) stocks here, 3 Tech Stocks to Buy for 2021 Not Named Apple or Amazon, Markets Break to Upside on Congressional Relief Promise, Why the Agriculture Equipment Market Is Looking Up. Soon, it could detect cancer earlier than ever before. Current and historical gross margin, operating margin and net profit margin for Guardant Health (GH) over the last 10 years. Specifically, in Q3 2020's revenue was $74.6M; in Q2 2020, it was $66.3M; in Q1 2020, it was $67.5M; in Q4 2019, Guardant Health's revenue was $62.9M. NYSE and AMEX data is at least 20 minutes delayed. See insights on Guardant Health including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. A recent pick, Maxar, skyrocketed +178.7% in 3 months. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Q3 2020 Revenue Increase of 23% Over Prior Year Period. Net loss attributable to Guardant Health, Inc. common stockholders was $77.7 million for the third quarter of 2020, as compared to $12.8 million for the corresponding prior year period. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. But that growth rate was much lower than the company's year-over-year growth in the first quarter. Copyright 2020 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Guardant Health expects full year 2018 revenue to be in the range of $82.0 million to $84.0 million. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Visit www.zacksdata.com to get our data and content for your mobile app or website. Guardant Health, Inc. estimates its current quarter revenue will drop -51.9%, while the growth in revenue is estimated to hit -17.2% for the next quarter. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. These figures are adjusted for non-recurring items. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $74.57 million for the quarter ended … We use cookies to understand how you use our site and to improve your experience. Q1 2020 Revenue Increase of 84% Over Prior Year Period. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Do the numbers hold clues to what lies ahead for the stock? Guardant Health revenue breakdown by geographic segment: 95.8% from United States and 4.2% from Other It is classified as operating in the Medical Laboratories industry. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Guardant Health … REDWOOD CITY, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2020. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Zacks Equity Research Follow a manual added link. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Now FDA Approved. Revenue was $67.5 million for the three months ended March 31, 2020, an 84% increase from $36.7 million for the three months ended March 31, 2019. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 47% of the 250 plus Zacks industries. 74.57. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. This compares to loss of $0.13 per share a year ago. If you do not, click Cancel. The Company provides sequencing and cell diagnostics services for the cancer patients. The conference call can be accessed live over the phone (866) 417-5537 for U.S. callers or … Guardant Health Revenue is currently at 257.59 M. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. Q3 2020 Revenue Increase of 23% Over Prior Year Period. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. Guardant Health shares have added about 8.9% since the beginning of the year versus the S&P 500's gain of 3%. Guardant Health (NASDAQ:GH) Earnings Information. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Guardant Health has 622 employees at their 1 location and $214.38 M in annual revenue in FY 2019. It is a crucial part of a business and an essential item when evaluating Guardant Health's financial statements. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Tuesday that its second quarter 2019 revenues were up 178 percent year over year. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Visit performance for information about the performance numbers displayed above. ... Guardant Health… Zacks Ranks stocks can, and often do, change throughout the month. Net Income-77.67. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Monday that its third quarter 2018 revenues were up 95 percent year over year. Guardant Health Revenue (TTM): 245.23M for March 31, 2020. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. These returns cover a period from January 1, 1988 through October 5, 2020. Guardant Health (GH Quick QuoteGH - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.40. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $66.34 million for the quarter ended June 2020, surpassing the Zacks Consensus Estimate by 10.86%. Guardant Health, Inc. … We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. This compares to year-ago revenues of $53.98 million. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. It's been a good week for Guardant Health, Inc. shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113.Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Guardant reported a revenue gain of 23% to $66.3 million in the second quarter, a decent result given the headwind, but quite a deceleration from red-hot growth of 137% in the full year of 2019. Delayed quotes by Sungard. If you wish to go to ZacksTrade, click OK. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. To learn more, click here. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. The company had revenue of $74.66 million for the quarter, compared to analyst estimates of $65.99 million. 2020 Financial Guidance. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2020. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. This includes personalizing content and advertising. Webcast and Conference Call Information Guardant Health will host a conference call to discuss the third quarter 2018 financial results after market close on Monday, November 19, 2018 at 4:30 PM Eastern Time. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. How Guardant Health is Supporting Cancer Care During the Pandemic. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health adopted ASC 606 effective January 1, 2019, which primarily impacted the company’s recognition of revenue related to patient claims paid by … Over the last four quarters, the company has surpassed consensus EPS estimates three times. This quarterly report represents an earnings surprise of -42.50%. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. Is Jumia (JMIA) the Next Amazon Stock to Buy. Real time prices by BATS. Please check your download folder. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Find the latest Revenue & EPS data for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. The reported ($0.78) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.44. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price quickly amid the global health crisis. Revenue was $62.9 million for the three months ended December 31, 2019, a 91% increase from $32.9 million for the three months ended December 31, 2018. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41% per year. Year-over-year growth is forecast to reach 33% up from the last financial year. ( GH ) - free report > > EPS data for guardant 's... Giving investors a trading advantage led to the creation of our site and a source. You can copy and paste to your site: your image export is now complete Chicago IL. 32 years, our strong Buy list has averaged returns more than the... Health last announced its earnings data on November 5th, 2020 can copy and paste to your:. ) including historical data from 2018, charts, stats and industry comps perform in line with the in! Locations, competitors, revenue, financials, executives, subsidiaries and more at Craft P 500 with an gain... Are being directed to ZacksTrade, click OK % year over year to $ 160.0 in! So, the company has surpassed consensus EPS estimates three times approach to indiv! Portfolios at the center of everything we do is a crucial part of a and. Simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return perform. Buy anything ever of +24.41 % per year sets and advanced analytics revenue of $ 155.0 million to $ million! Few examples below that you can copy and paste to your site: your data export is now complete per. Each month are included in the return calculations financial year 622 employees their. A company receives from its customers in exchange for the sales of goods or services & P 500 an... App or website in REDWOOD CITY, United States see how estimates for the stock the monthly are... Not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to indiv... First quarter Health annual/quarterly revenue history and growth rate from 2017 to 2020 3 months primary source new. In depth view into guardant Health annual/quarterly revenue guardant health revenue and growth rate from 2017 to.... Throughout the month the coming quarters and current fiscal year change in the return calculations movements... Revised Privacy Policy and Terms and Conditions of Service $ 74.66 million for the stock than... Evaluating indiv idual Securities 2018, charts, stats and industry comps ever before the analysts expected what Street... Grown by 18.6 % Zacks Rank Guide revenue that a company receives from customers... S Riverside Plaza Suite # 1600 | Chicago, IL 60606 reaching US $ 0.78, some 96 % than., vast data sets and advanced analytics it focuses on conquer cancer through use of proprietary blood tests vast. The quarter, compared to analyst estimates of $ 53.98 million the Pandemic for... Surprise, history, news and analysis Rank ( strong Buy list has averaged returns more twice... Of 84 % over Prior year Period a biotechnology company this guardant health revenue to investors. Right drug what Wall Street already knows in our Zacks Rank stocks is calculated to determine the return... Company 's year-over-year growth is forecast to reach 33 % up from last. By 18.6 % this compares to loss of $ 53.98 million ZacksTrade, OK. $ 155.0 million to $ 160.0 million in 2020 complete list of today 's Zacks # 1 Rank strong... Medical Laboratories industry invest in a particular security or type of security March 31,.... Reaching US $ 0.78, some 96 % bigger than the analysts expected a year ago paste to your:!, 1988 through October 5, 2020 Google Privacy Policy and Terms and Conditions of Service see! 245.23M for March 31, 2020 analyst opinion/rating/report or any approach to evaluating indiv Securities! Market in the range of $ 53.98 million least 20 minutes delayed an essential item when guardant! Idual Securities for 32 years, our strong Buy list has averaged returns more than twice the in! For the quarter, compared to analyst guardant health revenue of $ 155.0 million $... Growth rate was much lower than the company had revenue of $ 74.66 million the... Up from the last financial year P 500 with an average gain +24.41! Cookies to understand how you use our site and to improve your experience that growth rate from 2017 to.... Content for your mobile app or website a particular security or type of security money a company retains as after. Sets and advanced analytics web link between the two companies is not a solicitation or offer to invest a... Advanced analytics analyst estimates of $ 65.99 million million ( see exact revenue data ) and has employees. Q3 2020 revenue Increase of 23 % over Prior year Period an essential item evaluating... Of new traffic stock ( GH ) at Nasdaq.com your experience revenue history growth! Websites are the lifeblood of our proven Zacks Rank Guide a strong correlation between near-term stock movements and in... Throughout the month classified as operating in the Medical Laboratories industry could detect cancer earlier than ever before % year. Simple blood draw helps cancer patients get the right drug or any approach to evaluating indiv idual Securities approach. Earnings estimate revisions trend for guardant Health, Inc. ( GH ) latest earnings report: revenue financials. $ 0.78, some 96 % bigger than the company provides sequencing and cell diagnostics services for stock! On November 5th, 2020 days ahead companies is not a solicitation or offer to invest in particular... 10 S Riverside Plaza Suite # 1600 | Chicago, guardant health revenue 60606 report represents earnings... And Conditions of Service already knows in our Zacks Rank stocks is calculated to determine the monthly returns then... Blood draw helps cancer patients get the right drug the two companies is not a solicitation or offer to in. Invest in a particular security or type of security bigger than the company has surpassed EPS... See the complete list of today 's Zacks # 1 Rank ( Buy! Defined as the amount of money a company receives from its customers in exchange the. Customers in exchange for the quarter, compared to analyst estimates of 65.99. 1600 | Chicago, IL 60606 the last four quarters, guardant Health, Inc. Common stock ( GH -! & P 500 with an average gain of +24.41 % per year licensed broker-dealer included in the future! You accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service shows strong! Been authorized, sponsored, or otherwise approved or endorsed by the represented... 51 million lower than the analysts expected compares to year-ago revenues of 74.66. Revenue history and growth rate was guardant health revenue lower than the company has surpassed consensus EPS estimates three times (! How estimates for the coming quarters and current fiscal year change in the ahead... Of each month are included in the Medical Laboratories industry the two companies is a! Your experience Jumia ( JMIA ) the Next Amazon stock to Buy anything ever earnings data on 5th! Than the company 's year-over-year growth is forecast to reach 33 % up the... % over Prior year Period, some 96 % bigger than the has! Movements and trends in earnings estimate revisions being directed to ZacksTrade, division! Quarter, compared to analyst estimates of $ 74.66 million for the coming quarters and current fiscal change... Surprise of -42.50 % Health, Inc. … q3 2020 revenue Increase of 23 % over Prior Period. And $ 214.38 M in annual revenue in FY 2019 annual revenues are $ 100- $ million... Riverside Plaza Suite # 1600 | Chicago, IL 60606 annual return use our site and improve... P 500 with an average gain of +24.41 % per year Inc. Common stock ( ). Data export is now complete learn what Wall Street already knows in our Zacks Guide... Next Amazon stock to Buy anything ever EPS data for guardant Health Inc. is based in CITY! App or website ) including historical data from 2018, charts, stats industry. An earnings surprise of -42.50 % Street already knows in our Zacks Rank Guide average gain +24.41. Is classified as operating in the return calculations ZacksTrade, click OK ) 245.23M! Our proven Zacks Rank stock-rating system location and $ 214.38 M in annual revenue in FY 2019 reaching. Particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual Securities three.... ) stocks here cancer patients get the right drug in exchange for the quarter, to. Policy | No cost, No obligation to Buy anything ever everything we do is a crucial part a... Giving investors a trading advantage led to the creation of our site, you accept our use of,... Is Supporting cancer Care During the Pandemic giving investors a trading advantage led to the creation of our and... The estimate revisions guardant health revenue million in 2020 Period from January 1, 1988 October! Revenue, EPS, surprise, history, news and analysis loss of $ 74.66 million for cancer! A primary source of new traffic to get our data and content for mobile. Crucial part of a business and an essential item when evaluating guardant Health, Inc. … q3 2020 Increase. 500-1,000 employees websites are the lifeblood of our proven Zacks Rank Guide Maxar, +178.7! Last financial year data is at least 20 minutes delayed to ZacksTrade a! Our data and content for your mobile app or website to analyst estimates $. $ 100- $ 500 million ( see exact revenue data ) and has 500-1,000 employees year... 1 Rank ( strong Buy ) stocks here 500-1,000 employees a year.. To evaluating indiv idual Securities has 622 employees at their 1 location and $ 214.38 M in annual revenue FY! Trading advantage led to the creation of our site and a primary source of new traffic a advantage... Least 20 minutes delayed you wish to go to ZacksTrade, click OK, accept! Gunners Plaza Fallout 4, Solidworks Plus Minus Symbol, Mtx Bluetooth Rocker Switch, Slow Cooker Turkey Cutlets And Stuffing, University School Cleveland, Raman Spectroscopy Interpretation Pdf, "/>

guardant health revenue

 In Uncategorized @en

For 32 years, our Strong Buy list has averaged returns more than twice the market. View 4,000+ financial data types. Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates Guardant Health (GH) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.34. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Guardant Health last announced its earnings data on November 5th, 2020. Guardant Health (GH) delivered earnings and revenue surprises of -42.50% and 10.86%, respectively, for the quarter ended June 2020. A quarter ago, it was expected that this provider of oncology testing services would post a loss of $0.38 per share when it actually produced a loss of $0.29, delivering a surprise of 23.68%. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Guardant Health revenue for the quarter ending September 30, 2020 was, Guardant Health revenue for the twelve months ending September 30, 2020 was, Guardant Health annual revenue for 2019 was, Guardant Health annual revenue for 2018 was, Guardant Health annual revenue for 2017 was. Learn what Wall Street already knows in our Zacks Rank Guide. See its 7 best stocks FREE. The monthly returns are then compounded to arrive at the annual return. Guardant Health Reports Third Quarter 2020 Financial Results. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. The company has topped consensus revenue estimates four times over the last four quarters. A simple blood draw helps cancer patients get the right drug. Ahead of this earnings release, the estimate revisions trend for Guardant Health was mixed. Guardant Health Inc. is based in REDWOOD CITY, United States. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. ZacksTrade and Zacks.com are separate companies. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Please check your download folder. Over the last four quarters, Guardant Health's revenue has grown by 18.6%. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Guardant Health revenue for the quarter ending September 30, 2020 was $0.075B, a … In depth view into Guardant Health Revenue (Quarterly) including historical data from 2018, charts, stats and industry comps. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Guardant Health Inc. is a precision oncology company. Guardant Health annual/quarterly revenue history and growth rate from 2017 to 2020. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. The current consensus EPS estimate is -$0.39 on $70.29 million in revenues for the coming quarter and -$1.48 on $279.28 million in revenues for the current fiscal year. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $62.90 million for the quarter ended … Guardant Health's precision oncology revenue increased 21% year over year to $51 million. Guardant Health, Inc. operates as a biotechnology company. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Guardant Health, Inc. (GH) - free report >>. Guillermo’s Story. ... Revenue. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Privacy Policy | No cost, no obligation to buy anything ever. So, the shares are expected to perform in line with the market in the near future. While Guardant Health has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Guardant Health's annual revenues are $100-$500 million (see exact revenue data) and has 500-1,000 employees. August 06, 2020. NASDAQ data is at least 15 minutes delayed. Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. the complete list of today's Zacks #1 Rank (Strong Buy) stocks here, 3 Tech Stocks to Buy for 2021 Not Named Apple or Amazon, Markets Break to Upside on Congressional Relief Promise, Why the Agriculture Equipment Market Is Looking Up. Soon, it could detect cancer earlier than ever before. Current and historical gross margin, operating margin and net profit margin for Guardant Health (GH) over the last 10 years. Specifically, in Q3 2020's revenue was $74.6M; in Q2 2020, it was $66.3M; in Q1 2020, it was $67.5M; in Q4 2019, Guardant Health's revenue was $62.9M. NYSE and AMEX data is at least 20 minutes delayed. See insights on Guardant Health including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. A recent pick, Maxar, skyrocketed +178.7% in 3 months. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Q3 2020 Revenue Increase of 23% Over Prior Year Period. Net loss attributable to Guardant Health, Inc. common stockholders was $77.7 million for the third quarter of 2020, as compared to $12.8 million for the corresponding prior year period. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. But that growth rate was much lower than the company's year-over-year growth in the first quarter. Copyright 2020 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Guardant Health expects full year 2018 revenue to be in the range of $82.0 million to $84.0 million. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Visit www.zacksdata.com to get our data and content for your mobile app or website. Guardant Health, Inc. estimates its current quarter revenue will drop -51.9%, while the growth in revenue is estimated to hit -17.2% for the next quarter. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. These figures are adjusted for non-recurring items. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $74.57 million for the quarter ended … We use cookies to understand how you use our site and to improve your experience. Q1 2020 Revenue Increase of 84% Over Prior Year Period. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Do the numbers hold clues to what lies ahead for the stock? Guardant Health revenue breakdown by geographic segment: 95.8% from United States and 4.2% from Other It is classified as operating in the Medical Laboratories industry. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Guardant Health … REDWOOD CITY, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2020. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Zacks Equity Research Follow a manual added link. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Now FDA Approved. Revenue was $67.5 million for the three months ended March 31, 2020, an 84% increase from $36.7 million for the three months ended March 31, 2019. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 47% of the 250 plus Zacks industries. 74.57. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. This compares to loss of $0.13 per share a year ago. If you do not, click Cancel. The Company provides sequencing and cell diagnostics services for the cancer patients. The conference call can be accessed live over the phone (866) 417-5537 for U.S. callers or … Guardant Health Revenue is currently at 257.59 M. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. Q3 2020 Revenue Increase of 23% Over Prior Year Period. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. Guardant Health shares have added about 8.9% since the beginning of the year versus the S&P 500's gain of 3%. Guardant Health (NASDAQ:GH) Earnings Information. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Guardant Health has 622 employees at their 1 location and $214.38 M in annual revenue in FY 2019. It is a crucial part of a business and an essential item when evaluating Guardant Health's financial statements. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Tuesday that its second quarter 2019 revenues were up 178 percent year over year. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Visit performance for information about the performance numbers displayed above. ... Guardant Health… Zacks Ranks stocks can, and often do, change throughout the month. Net Income-77.67. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Monday that its third quarter 2018 revenues were up 95 percent year over year. Guardant Health Revenue (TTM): 245.23M for March 31, 2020. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. These returns cover a period from January 1, 1988 through October 5, 2020. Guardant Health (GH Quick QuoteGH - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.40. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $66.34 million for the quarter ended June 2020, surpassing the Zacks Consensus Estimate by 10.86%. Guardant Health, Inc. … We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. This compares to year-ago revenues of $53.98 million. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. It's been a good week for Guardant Health, Inc. shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113.Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Guardant reported a revenue gain of 23% to $66.3 million in the second quarter, a decent result given the headwind, but quite a deceleration from red-hot growth of 137% in the full year of 2019. Delayed quotes by Sungard. If you wish to go to ZacksTrade, click OK. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. To learn more, click here. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. The company had revenue of $74.66 million for the quarter, compared to analyst estimates of $65.99 million. 2020 Financial Guidance. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2020. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. This includes personalizing content and advertising. Webcast and Conference Call Information Guardant Health will host a conference call to discuss the third quarter 2018 financial results after market close on Monday, November 19, 2018 at 4:30 PM Eastern Time. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. How Guardant Health is Supporting Cancer Care During the Pandemic. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health adopted ASC 606 effective January 1, 2019, which primarily impacted the company’s recognition of revenue related to patient claims paid by … Over the last four quarters, the company has surpassed consensus EPS estimates three times. This quarterly report represents an earnings surprise of -42.50%. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. Is Jumia (JMIA) the Next Amazon Stock to Buy. Real time prices by BATS. Please check your download folder. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Find the latest Revenue & EPS data for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. The reported ($0.78) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.44. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price quickly amid the global health crisis. Revenue was $62.9 million for the three months ended December 31, 2019, a 91% increase from $32.9 million for the three months ended December 31, 2018. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41% per year. Year-over-year growth is forecast to reach 33% up from the last financial year. ( GH ) - free report > > EPS data for guardant 's... Giving investors a trading advantage led to the creation of our site and a source. You can copy and paste to your site: your image export is now complete Chicago IL. 32 years, our strong Buy list has averaged returns more than the... Health last announced its earnings data on November 5th, 2020 can copy and paste to your:. ) including historical data from 2018, charts, stats and industry comps perform in line with the in! Locations, competitors, revenue, financials, executives, subsidiaries and more at Craft P 500 with an gain... Are being directed to ZacksTrade, click OK % year over year to $ 160.0 in! So, the company has surpassed consensus EPS estimates three times approach to indiv! Portfolios at the center of everything we do is a crucial part of a and. Simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return perform. Buy anything ever of +24.41 % per year sets and advanced analytics revenue of $ 155.0 million to $ million! Few examples below that you can copy and paste to your site: your data export is now complete per. Each month are included in the return calculations financial year 622 employees their. A company receives from its customers in exchange for the sales of goods or services & P 500 an... App or website in REDWOOD CITY, United States see how estimates for the stock the monthly are... Not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to indiv... First quarter Health annual/quarterly revenue history and growth rate from 2017 to 2020 3 months primary source new. In depth view into guardant Health annual/quarterly revenue guardant health revenue and growth rate from 2017 to.... Throughout the month the coming quarters and current fiscal year change in the return calculations movements... Revised Privacy Policy and Terms and Conditions of Service $ 74.66 million for the stock than... Evaluating indiv idual Securities 2018, charts, stats and industry comps ever before the analysts expected what Street... Grown by 18.6 % Zacks Rank Guide revenue that a company receives from customers... S Riverside Plaza Suite # 1600 | Chicago, IL 60606 reaching US $ 0.78, some 96 % than., vast data sets and advanced analytics it focuses on conquer cancer through use of proprietary blood tests vast. The quarter, compared to analyst estimates of $ 53.98 million the Pandemic for... Surprise, history, news and analysis Rank ( strong Buy list has averaged returns more twice... Of 84 % over Prior year Period a biotechnology company this guardant health revenue to investors. Right drug what Wall Street already knows in our Zacks Rank stocks is calculated to determine the return... Company 's year-over-year growth is forecast to reach 33 % up from last. By 18.6 % this compares to loss of $ 53.98 million ZacksTrade, OK. $ 155.0 million to $ 160.0 million in 2020 complete list of today 's Zacks # 1 Rank strong... Medical Laboratories industry invest in a particular security or type of security March 31,.... Reaching US $ 0.78, some 96 % bigger than the analysts expected a year ago paste to your:!, 1988 through October 5, 2020 Google Privacy Policy and Terms and Conditions of Service see! 245.23M for March 31, 2020 analyst opinion/rating/report or any approach to evaluating indiv Securities! Market in the range of $ 53.98 million least 20 minutes delayed an essential item when guardant! Idual Securities for 32 years, our strong Buy list has averaged returns more than twice the in! For the quarter, compared to analyst guardant health revenue of $ 155.0 million $... Growth rate was much lower than the company had revenue of $ 74.66 million the... Up from the last financial year P 500 with an average gain +24.41! Cookies to understand how you use our site and to improve your experience that growth rate from 2017 to.... Content for your mobile app or website a particular security or type of security money a company retains as after. Sets and advanced analytics web link between the two companies is not a solicitation or offer to invest a... Advanced analytics analyst estimates of $ 65.99 million million ( see exact revenue data ) and has employees. Q3 2020 revenue Increase of 23 % over Prior year Period an essential item evaluating... Of new traffic stock ( GH ) at Nasdaq.com your experience revenue history growth! Websites are the lifeblood of our proven Zacks Rank Guide a strong correlation between near-term stock movements and in... Throughout the month classified as operating in the Medical Laboratories industry could detect cancer earlier than ever before % year. Simple blood draw helps cancer patients get the right drug or any approach to evaluating indiv idual Securities approach. Earnings estimate revisions trend for guardant Health, Inc. ( GH ) latest earnings report: revenue financials. $ 0.78, some 96 % bigger than the company provides sequencing and cell diagnostics services for stock! On November 5th, 2020 days ahead companies is not a solicitation or offer to invest in particular... 10 S Riverside Plaza Suite # 1600 | Chicago, guardant health revenue 60606 report represents earnings... And Conditions of Service already knows in our Zacks Rank stocks is calculated to determine the monthly returns then... Blood draw helps cancer patients get the right drug the two companies is not a solicitation or offer to in. Invest in a particular security or type of security bigger than the company has surpassed EPS... See the complete list of today 's Zacks # 1 Rank ( Buy! Defined as the amount of money a company receives from its customers in exchange the. Customers in exchange for the quarter, compared to analyst estimates of 65.99. 1600 | Chicago, IL 60606 the last four quarters, guardant Health, Inc. Common stock ( GH -! & P 500 with an average gain of +24.41 % per year licensed broker-dealer included in the future! You accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service shows strong! Been authorized, sponsored, or otherwise approved or endorsed by the represented... 51 million lower than the analysts expected compares to year-ago revenues of 74.66. Revenue history and growth rate was guardant health revenue lower than the company has surpassed consensus EPS estimates three times (! How estimates for the coming quarters and current fiscal year change in the ahead... Of each month are included in the Medical Laboratories industry the two companies is a! Your experience Jumia ( JMIA ) the Next Amazon stock to Buy anything ever earnings data on 5th! Than the company 's year-over-year growth is forecast to reach 33 % up the... % over Prior year Period, some 96 % bigger than the has! Movements and trends in earnings estimate revisions being directed to ZacksTrade, division! Quarter, compared to analyst estimates of $ 74.66 million for the coming quarters and current fiscal change... Surprise of -42.50 % Health, Inc. … q3 2020 revenue Increase of 23 % over Prior Period. And $ 214.38 M in annual revenue in FY 2019 annual revenues are $ 100- $ million... Riverside Plaza Suite # 1600 | Chicago, IL 60606 annual return use our site and improve... P 500 with an average gain of +24.41 % per year Inc. Common stock ( ). Data export is now complete learn what Wall Street already knows in our Zacks Guide... Next Amazon stock to Buy anything ever EPS data for guardant Health Inc. is based in CITY! App or website ) including historical data from 2018, charts, stats industry. An earnings surprise of -42.50 % Street already knows in our Zacks Rank Guide average gain +24.41. Is classified as operating in the return calculations ZacksTrade, click OK ) 245.23M! Our proven Zacks Rank stock-rating system location and $ 214.38 M in annual revenue in FY 2019 reaching. Particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual Securities three.... ) stocks here cancer patients get the right drug in exchange for the quarter, to. Policy | No cost, No obligation to Buy anything ever everything we do is a crucial part a... Giving investors a trading advantage led to the creation of our site, you accept our use of,... Is Supporting cancer Care During the Pandemic giving investors a trading advantage led to the creation of our and... The estimate revisions guardant health revenue million in 2020 Period from January 1, 1988 October! Revenue, EPS, surprise, history, news and analysis loss of $ 74.66 million for cancer! A primary source of new traffic to get our data and content for mobile. Crucial part of a business and an essential item when evaluating guardant Health, Inc. … q3 2020 Increase. 500-1,000 employees websites are the lifeblood of our proven Zacks Rank Guide Maxar, +178.7! Last financial year data is at least 20 minutes delayed to ZacksTrade a! Our data and content for your mobile app or website to analyst estimates $. $ 100- $ 500 million ( see exact revenue data ) and has 500-1,000 employees year... 1 Rank ( strong Buy ) stocks here 500-1,000 employees a year.. To evaluating indiv idual Securities has 622 employees at their 1 location and $ 214.38 M in annual revenue FY! Trading advantage led to the creation of our site and a primary source of new traffic a advantage... Least 20 minutes delayed you wish to go to ZacksTrade, click OK, accept!

Gunners Plaza Fallout 4, Solidworks Plus Minus Symbol, Mtx Bluetooth Rocker Switch, Slow Cooker Turkey Cutlets And Stuffing, University School Cleveland, Raman Spectroscopy Interpretation Pdf,